ResearcherCapital Medical UniversityActive in the last 2 years

Xin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4715-4360; OpenAlex author ID A5100668403. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Exploring the survival benefits of surgical treatment for pancreatic adenocarcinoma using the DeepSurv neural network model. Co-author DOI 10.1080/24699322.2025.2556334 ↗
High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA databas… Co-author DOI 10.1097/md.0000000000035595 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongyi Zhang · 1 shared paper, 2025 · strength 0.30
- Paper Exploring the survival benefits of surgical treatment for pancreatic adenocarcinoma using the DeepSurv neural network m… DOI 10.1080/24699322.2025.2556334 ↗
Wei Wu · 1 shared paper, 2023 · strength 0.19
- Paper High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenoc… DOI 10.1097/md.0000000000035595 ↗
Pengji Gao · 1 shared paper, 2023 · strength 0.19
- Paper High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenoc… DOI 10.1097/md.0000000000035595 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.